Silvercrest Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
BFA
CIP
BIT
Silvercrest Asset Management's IART Position: Q4 2016 in Review
Silvercrest Asset Management sold out of Integra LifeSciences (IART) in Q4 2016, closing a stake of 491,318 shares — an estimated $20.3M sold.
Silvercrest Asset Management first reported a position in IART in Q2 2013 and held it in 14 quarters. The position peaked at $46.1M in Q1 2016. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.
- Silvercrest Asset Management reported no remaining Integra LifeSciences position as of Q4 2016 after selling out during the quarter.
- Silvercrest Asset Management sold 491,318 Integra LifeSciences shares in Q4 2016, an estimated $20.3M.
- Silvercrest Asset Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 14 quarters.
- Silvercrest Asset Management's Integra LifeSciences position peaked at $46.1M in Q1 2016.
- 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.
Based on Silvercrest Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.